Anktiva (nogapendekin alfa inbakicept-pmln)
(nogapendekin alfa inbakicept-pmln)Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
Usage: ANKTIVA, in combination with Bacillus Calmette-Guérin (BCG), is indicated for treating adult patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.